Internal Medicine, Allergy & Immunology · Saint Louis, MO
NPI
1386661809
Since 2006
Specialty
Internal Medicine, Allergy & Immunology
Code 207RA0201X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
10 Barnes West Dr, Div Im Allergy and Immunology, Ste 200
Saint Louis, MO, 63141
Phone (314) 996-8670
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
64,226 services
Medicare patients, 2024
359
Average age 72
Drug cost, 2024
$10.3M
2,305 prescriptions
Company payments, 2025
$59K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by H J Wedner was code J3380 (injection, vedolizumab, intravenous, 1 mg), 15,600 times for 17 patients. In total H J Wedner billed 64,226 services in 56 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 15,600 | 17 | $17.35 | $271K |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 8,660 | 26 | $38.56 | $334K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 3,250 | 12 | $9.07 | $29K |
| J0897 Injection, denosumab, 1 mg | Office | 3,180 | 52 | $19.78 | $63K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,650 | 11 | $24.89 | $41K |
| 95165 Treatment - Miscellaneous | Office | 316 | 19 | $10.17 | $3,215 |
| 96365 Intravenous Infusion, Hydration | Office | 293 | 98 | $43.22 | $13K |
| 96366 Intravenous Infusion, Hydration | Office | 236 | 39 | $14.34 | $3,385 |
| 99214 Office E&M - Established | Office | 232 | 123 | $90.24 | $21K |
| 96372 Injection Administration | Office | 187 | 73 | $9.44 | $1,765 |
| 95117 Treatment - Miscellaneous | Office | 115 | 38 | $7.01 | $806 |
| 94010 Pulmonary Function Testing | Office | 38 | 36 | $12.52 | $476 |
| 94618 Pulmonary Function Testing | Office | 27 | 27 | $8.18 | $221 |
| 94729 Pulmonary Function Testing | Office | 20 | 20 | $30.46 | $609 |
| 94726 Pulmonary Function Testing | Office | 11 | 11 | $30.07 | $331 |
By year: 2022 $960K for 45,244 services; 2023 $1.1M for 56,537 services; 2024 $1.3M for 64,226 services.
Medicare prescription drug claims, 2024
In 2024, the drug H J Wedner prescribed most often to Medicare patients was Montelukast Sodium, with 281 prescriptions and refills. In total H J Wedner wrote 2,305 Medicare prescriptions that cost $10.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 281 | 659 | 78 | $3,182 |
| Fluticasone Propionate Generic | 178 | 300 | 53 | $2,706 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 164 | 201 | 53 | $4,830 |
| Ipratropium Bromide Generic | 151 | 259 | 52 | $5,358 |
| Breo Ellipta Fluticasone/Vilanterol | 99 | 123 | 17 | $50K |
| Azelastine Hcl Generic | 89 | 154 | 30 | $2,434 |
| Famotidine Generic | 81 | 177 | 23 | $1,059 |
| Doxepin Hcl Generic | 62 | 89 | 11 | $2,038 |
| Dupixent Syringe Dupilumab | 62 | 62 | Under 11 | $234K |
| Epinephrine Generic | 59 | 61 | 38 | $9,441 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 50 | 50 | Under 11 | $335K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 47 | 77 | Under 11 | $47K |
| Symbicort Budesonide/Formoterol Fumarate | 38 | 64 | 15 | $15K |
| Levocetirizine Dihydrochloride Generic | 37 | 95 | 11 | $407 |
| Takhzyro Lanadelumab-Flyo | 35 | 36 | Under 11 | $1.4M |
Brand drugs: 811 claims; generic drugs: 1,494 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid H J Wedner $59K ($59K in general payments such as food, travel and fees) from 15 companies. The largest payer was Ionis Pharmaceuticals, Inc. with $34K.
| Company | Payments | Amount |
|---|---|---|
| Ionis Pharmaceuticals, Inc. IONS | 19 | $34K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $16K |
| Grifols USA, LLC | 1 | $2,140 |
| Genentech USA, Inc. ROG.SW | 3 | $1,771 |
| CSL Behring CSL.AX | 1 | $1,438 |
| Sanofi US Services Inc. SNY | 1 | $1,330 |
| Grifols Shared Services North America, Inc. | 1 | $950 |
| Blueprint Medicines Corporation SNY | 1 | $499 |
| Genzyme Corporation SNY | 2 | $125 |
| BioCryst US Sales Co., LLC | 1 | $123 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.